Understanding the Prescribing Patterns of Lipid-Lowering Agents in the United States and Canada

被引：0
|
作者：
Reynolds, Matthew W. [1 ]
Moride, Yola [2 ]
机构：
[1] United BioSource Corp, Lexington, MA USA
[2] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2009年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [41] Trends in Lipid-Lowering Prescriptions by Statin Intensity - United States, 2017-202
    Sekkarie, Ahlia
    Park, Soyoun
    Therrien, Nicole L.
    Jackson, Sandra
    Woodruff, Rebecca
    Attipoe-Dorcoo, Sharon
    Yang, Peter
    Sperling, Laurence
    Loustalot, Fleetwood V.
    Thompson-Paul, Angela M.
    CIRCULATION, 2022, 146
  • [42] Differential effects of lipid-lowering agents on human cholinesterases
    Darvesh, S
    Martin, E
    Walsh, R
    Rockwood, K
    CLINICAL BIOCHEMISTRY, 2004, 37 (01) : 42 - 49
  • [43] Myotoxicity of Lipid-Lowering Agents in a Teenager With MELAS Mutation
    Tay, Stacey K. H.
    DiMauro, Salvatore
    Pang, Aileen Y. W.
    Lai, Poh-San
    Yap, Hui-Kim
    PEDIATRIC NEUROLOGY, 2008, 39 (06) : 426 - 428
  • [44] Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction
    Amarenco, P
    NEUROLOGY, 2001, 57 (05) : S35 - S44
  • [45] Should lipid-lowering agents be prescribed in the case of myasthenia
    Windler, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 121 (03) : 80 - 80
  • [46] Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?
    Jeffrey E. Alfonsi
    Robert A. Hegele
    Steven E. Gryn
    Current Atherosclerosis Reports, 2016, 18
  • [47] Lipid-lowering agents and fibrinolysis:: lack of effect in vitro
    Elzaher, SM
    Pallister, CJ
    Dunn, CDR
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2001, 58 (04) : 244 - 246
  • [48] Role of lipid-lowering agents in the management of diabetic retinopathy
    Ioannidou, Estelle
    Tseriotis, Vasilis-Spyridon
    Tziomalos, Konstantinos
    WORLD JOURNAL OF DIABETES, 2017, 8 (01) : 1 - 6
  • [49] Progress in Understanding the Antiobesity and Lipid-Lowering Mechanism of Gingerol
    Li Y.
    Li X.
    Yuan Y.
    Bai W.
    Jiao R.
    Shipin Kexue/Food Science, 2022, 43 (05): : 356 - 362
  • [50] IMPROVEMENT OF COMPLIANCE WITH LIPID-LOWERING AGENTS IMPROVEMENT OF THE COMPLIANCE OF LIPID-LOWERING MEDICATION. CONTROLLED STUDY IN COMMUNITY PHARMACY
    Andres Iglesias, J. Carlos
    Andres Rodriguez, N. Floro
    Fornos Perez, Jose A.
    FARMACEUTICOS COMUNITARIOS, 2009, 1 (03): : 92 - 98
12345